Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Non-syndromic hearing loss panel. 95-gene NGS panel. Genologica Medica Spain | 146 | 94 |
|
Optic atrophy panel. NGS panel of 19 genes. Genologica Medica Spain | 38 | 19 |
|
Retinal dystrophy panel. 260 gene NGS panel. Genologica Medica Spain | 420 | 257 |
|
Neuro-ophthalmology panel. NGS panel of 38 genes. Genologica Medica Spain | 75 | 38 |
|
Comprehensive panel of monogenic diabetes. 28-gene NGS panel. Genologica Medica Spain | 60 | 28 |
|
Mitochondrial genome sequencing Molecular Vision Laboratory United States | 526 | 339 |
|
Institute for Human Genetics University Medical Center Freiburg Germany | 5 | 1 |
|
Mitochondrial Panel, Nuclear genes CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 145 | 134 |
|
Hearing Loss, Comprehensive Panel CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 142 | 84 |
|
Deafness, autosomal dominant: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 40 | 39 |
|
Comprehensive Metabolism NGS Panel Fulgent Genetics United States | 602 | 355 |
|
Congenital Cataracts NGS Panel Fulgent Genetics United States | 106 | 56 |
|
Syndromic Hearing Loss NGS Panel Fulgent Genetics United States | 223 | 83 |
|
Comprehensive Hearing Loss NGS Panel Fulgent Genetics United States | 332 | 167 |
|
Neuro-Ophthalmic Disorders NGS Panel Fulgent Genetics United States | 52 | 26 |
|
Fulgent Genetics United States | 505 | 132 |
|
Nonsyndromic Hearing Loss NGS Panel Fulgent Genetics United States | 146 | 99 |
|
Fulgent Genetics United States | 533 | 149 |
|
Hearing Loss Advanced Sequencing and CNV Evaluation Athena Diagnostics United States | 249 | 184 |
|
WFS1-Related Disorders: gene sequencing CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 3 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.